Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of PIP4K2B mRNA | increases expression | 19933214
|
C014347 |
decitabine |
decitabine results in decreased expression of PIP4K2B mRNA | decreases expression | 19194470
|
D015741 |
Metribolone |
Metribolone results in decreased expression of PIP4K2B mRNA | decreases expression | 17010675
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PIP4K2B mRNA | affects binding|increases activity|increases expression | 19710929
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PIP4K2B mRNA | increases expression | 19933214
|
D013752 |
Tetracycline |
Tetracycline results in decreased expression of PIP4K2B mRNA | decreases expression | 16917069
|
D014501 |
Uranium |
Uranium affects the expression of PIP4K2B mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of PIP4K2B mRNA | affects expression | 15672453
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 11752688 14514962 15322242 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.05 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.05 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.59 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.59 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.07 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.07 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.65 | 19215824 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 16120746 18850075 18670907 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.00 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 12621046 8697196 16354765 15340226 15668235 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.37 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.24 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
4.24 | 17522070 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.35 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.35 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 15322242 18230668 16714409 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.49 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.82 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
8.82 | 19224547 16917069 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.25 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.64 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.67 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.30 | 19772884 19176532 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.30 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 8697196 15340226 16354765 18606429 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.35 | 17581917 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.96 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.18 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.24 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.41 | 18206229 18460780 19387464 17679729 18704418 19010910 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.84 | 18055864 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.19 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.51 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.51 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.24 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.58 | 19470736 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.27 | 16505122 17785578 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.51 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.51 | 19157545 18608210 19010910 16882708 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.22 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.37 | 17925555 19470736 19116145 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.37 | 17405874 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
5.16 | 9884423 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.71 | 19259094 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.84 | 19294695 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
5.81 | 11026799 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11118676 11399792 11896295 11222880 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.03 | 17616702 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
5.75 | 10903871 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.66 | 19155313 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.14 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.51 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
2.80 | 17616700 19087683 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.29 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |